Back
Avista Vs. Akero Therapeutics Industry Stock Comparison
Sell
48
AVA
Avista
Last Price:
$37.56
Seasonality Move:
0.12%
Buy
60
AKRO
Akero Therapeutics
Last Price:
$54.26
Seasonality Move:
13.24%
Sell
48
Avista (AVA)
is a Sell
Is Avista a Buy, Sell or Hold?
-
AVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.40. The Score for AKRO is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.40The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
AVA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 38.27 | Sell |
Chaikin Money Flow: | 796122 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.39 - 38.67) | Sell |
Bollinger Bands (100): | (37.38 - 40.88) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.21 | Buy |
Relative Strength Index (14 RSI): | 68.16 | Buy |
Chaikin Money Flow: | -55200 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.03 - 54.67) | Buy |
Bollinger Bands (100): | (38.49 - 52.07) | Buy |
AVA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.46 | Sell |
20-day SMA: | 37.95 | Sell |
50-day SMA: | 39.51 | Sell |
200-day SMA: | 38.36 | Sell |
8-day EMA: | 37.46 | Sell |
20-day EMA: | 37.99 | Sell |
50-day EMA: | 38.81 | Sell |
200-day EMA: | 38.37 | Sell |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.6 | Buy |
20-day SMA: | 51.32 | Buy |
50-day SMA: | 44.44 | Buy |
200-day SMA: | 37.08 | Buy |
8-day EMA: | 54.3 | Buy |
20-day EMA: | 51.28 | Buy |
50-day EMA: | 47.04 | Buy |
200-day EMA: | 38.9 | Buy |
Avista Earnings Growth & AVA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.10 per share, an increase this year of $0.23 per share, and an increase next year of $0.19 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.
Avista Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |